Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Free will beliefs are better predicted by dualism than determinism beliefs across different cultures.

Wisniewski D, Deutschländer R, Haynes JD.

PLoS One. 2019 Sep 11;14(9):e0221617. doi: 10.1371/journal.pone.0221617. eCollection 2019.

2.

In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa.

Young K, Painter RE, Raghoobar SL, Hairston NN, Racine F, Wisniewski D, Balibar CJ, Villafania A, Zhang R, Sahm DF, Blizzard T, Murgolo N, Hammond ML, Motyl MR.

BMC Microbiol. 2019 Jul 4;19(1):150. doi: 10.1186/s12866-019-1522-7.

3.

Mapping the Emergent Spatial Organization of Mammalian Cells using Micropatterns and Quantitative Imaging.

Wisniewski D, Lowell S, Blin G.

J Vis Exp. 2019 Apr 30;(146). doi: 10.3791/59634.

PMID:
31107437
4.

Fingerprinting Electronic Structure in Nanomaterials: A Methodology Illustrated by ZnSe Nanowires.

Wisniewski D, Byrne K, Fernandes C, Stewart C, de Souza CF, Ruda HE.

Nano Lett. 2019 Apr 10;19(4):2259-2266. doi: 10.1021/acs.nanolett.8b04646. Epub 2019 Mar 19.

PMID:
30888829
5.

Regulating Craving by Anticipating Positive and Negative Outcomes: A Multivariate Pattern Analysis and Network Connectivity Approach.

Kruschwitz JD, Ludwig VU, Waller L, List D, Wisniewski D, Wolfensteller U, Goschke T, Walter H.

Front Behav Neurosci. 2018 Dec 4;12:297. doi: 10.3389/fnbeh.2018.00297. eCollection 2018.

6.

Context-Dependence and Context-Invariance in the Neural Coding of Intentional Action.

Wisniewski D.

Front Psychol. 2018 Nov 27;9:2310. doi: 10.3389/fpsyg.2018.02310. eCollection 2018.

7.

Enhancement of transport properties in single ZnSe nanowire field-effect transistors.

Wisniewski D, Byrne K, de Souza CF, Fernandes C, Ruda HE.

Nanotechnology. 2019 Feb 1;30(5):054007. doi: 10.1088/1361-6528/aaf0d9. Epub 2018 Dec 5.

PMID:
30517086
8.

Anticipating the good and the bad: A study on the neural correlates of bivalent emotion anticipation and their malleability via attentional deployment.

Kruschwitz JD, Waller L, List D, Wisniewski D, Ludwig VU, Korb F, Wolfensteller U, Goschke T, Walter H.

Neuroimage. 2018 Dec;183:553-564. doi: 10.1016/j.neuroimage.2018.08.048. Epub 2018 Aug 23.

PMID:
30145207
9.

Geometrical confinement controls the asymmetric patterning of brachyury in cultures of pluripotent cells.

Blin G, Wisniewski D, Picart C, Thery M, Puceat M, Lowell S.

Development. 2018 Sep 21;145(18). pii: dev166025. doi: 10.1242/dev.166025.

10.

Nicotine induces oral dysplastic keratinocyte migration via fatty acid synthase-dependent epidermal growth factor receptor activation.

Wisniewski DJ, Ma T, Schneider A.

Exp Cell Res. 2018 Sep 15;370(2):343-352. doi: 10.1016/j.yexcr.2018.06.036. Epub 2018 Jun 30.

11.

An examination of refreshing in between-category sequences.

Langerock N, Wisniewski D, Brass M, Vergauwe E.

Ann N Y Acad Sci. 2018 Jul;1424(1):190-201. doi: 10.1111/nyas.13702. Epub 2018 May 9.

PMID:
29744894
12.

Radiation resistant PIDECα cell using photon intermediate direct energy conversion and a 210Po source.

Weaver CL, Schott RJ, Prelas MA, Wisniewski DA, Rothenberger JB, Lukosi ED, Oh K.

Appl Radiat Isot. 2018 Feb;132:110-115. doi: 10.1016/j.apradiso.2017.11.026. Epub 2017 Nov 28.

PMID:
29197822
13.

Switch-Independent Task Representations in Frontal and Parietal Cortex.

Loose LS, Wisniewski D, Rusconi M, Goschke T, Haynes JD.

J Neurosci. 2017 Aug 16;37(33):8033-8042. doi: 10.1523/JNEUROSCI.3656-16.2017. Epub 2017 Jul 20.

14.

Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy.

Myers RW, Guan HP, Ehrhart J, Petrov A, Prahalada S, Tozzo E, Yang X, Kurtz MM, Trujillo M, Gonzalez Trotter D, Feng D, Xu S, Eiermann G, Holahan MA, Rubins D, Conarello S, Niu X, Souza SC, Miller C, Liu J, Lu K, Feng W, Li Y, Painter RE, Milligan JA, He H, Liu F, Ogawa A, Wisniewski D, Rohm RJ, Wang L, Bunzel M, Qian Y, Zhu W, Wang H, Bennet B, LaFranco Scheuch L, Fernandez GE, Li C, Klimas M, Zhou G, van Heek M, Biftu T, Weber A, Kelley DE, Thornberry N, Erion MD, Kemp DM, Sebhat IK.

Science. 2017 Aug 4;357(6350):507-511. doi: 10.1126/science.aah5582. Epub 2017 Jul 13.

PMID:
28705990
15.

Dynamic nuclear polarisation by thermal mixing: quantum theory and macroscopic simulations.

Karabanov A, Kwiatkowski G, Perotto CU, Wiśniewski D, McMaster J, Lesanovsky I, Köckenberger W.

Phys Chem Chem Phys. 2016 Nov 2;18(43):30093-30104.

PMID:
27775111
16.

Properties of biochars from conventional and alternative feedstocks and their suitability for metal immobilization in industrial soil.

Gusiatin ZM, Kurkowski R, Brym S, Wiśniewski D.

Environ Sci Pollut Res Int. 2016 Nov;23(21):21249-21261. Epub 2016 Aug 5.

PMID:
27495921
17.

Similar coding of freely chosen and externally cued intentions in a fronto-parietal network.

Wisniewski D, Goschke T, Haynes JD.

Neuroimage. 2016 Jul 1;134:450-458. doi: 10.1016/j.neuroimage.2016.04.044. Epub 2016 Apr 21.

PMID:
27107470
18.

Solid effect DNP polarization dynamics in a system of many spins.

Wiśniewski D, Karabanov A, Lesanovsky I, Köckenberger W.

J Magn Reson. 2016 Mar;264:30-38. doi: 10.1016/j.jmr.2016.01.016.

PMID:
26920828
19.

Elucidation of DnaE as the Antibacterial Target of the Natural Product, Nargenicin.

Painter RE, Adam GC, Arocho M, DiNunzio E, Donald RG, Dorso K, Genilloud O, Gill C, Goetz M, Hairston NN, Murgolo N, Nare B, Olsen DB, Powles M, Racine F, Su J, Vicente F, Wisniewski D, Xiao L, Hammond M, Young K.

Chem Biol. 2015 Oct 22;22(10):1362-73. doi: 10.1016/j.chembiol.2015.08.015. Epub 2015 Oct 8.

20.

The Role of the Parietal Cortex in the Representation of Task-Reward Associations.

Wisniewski D, Reverberi C, Momennejad I, Kahnt T, Haynes JD.

J Neurosci. 2015 Sep 9;35(36):12355-65. doi: 10.1523/JNEUROSCI.4882-14.2015.

21.

Dynamic Nuclear Polarization as Kinetically Constrained Diffusion.

Karabanov A, Wiśniewski D, Lesanovsky I, Köckenberger W.

Phys Rev Lett. 2015 Jul 10;115(2):020404. Epub 2015 Jul 10.

PMID:
26207453
22.

The Neural Representation of Voluntary Task-Set Selection in Dynamic Environments.

Wisniewski D, Reverberi C, Tusche A, Haynes JD.

Cereb Cortex. 2015 Dec;25(12):4715-26. doi: 10.1093/cercor/bhu155. Epub 2014 Jul 17.

PMID:
25037922
23.

Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations.

Wiśniewski D, Porzezińska M, Gruchała-Niedoszytko M, Niedoszytko M, Słomiński JM, Jassem E.

Pneumonol Alergol Pol. 2014;82(2):96-104. doi: 10.5603/PiAP.2014.0015.

24.

Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®.

Blizzard TA, Chen H, Kim S, Wu J, Bodner R, Gude C, Imbriglio J, Young K, Park YW, Ogawa A, Raghoobar S, Hairston N, Painter RE, Wisniewski D, Scapin G, Fitzgerald P, Sharma N, Lu J, Ha S, Hermes J, Hammond ML.

Bioorg Med Chem Lett. 2014 Feb 1;24(3):780-5. doi: 10.1016/j.bmcl.2013.12.101. Epub 2014 Jan 3.

PMID:
24433862
25.

Automatic processing of political preferences in the human brain.

Tusche A, Kahnt T, Wisniewski D, Haynes JD.

Neuroimage. 2013 May 15;72:174-82. doi: 10.1016/j.neuroimage.2013.01.020. Epub 2013 Jan 24.

PMID:
23353599
26.

Utilizing HaloTag Technology to Track the Fate of PCSK9 from Intracellular vs. Extracellular Sources.

Ai X, Fischer P, Palyha OC, Wisniewski D, Hubbard B, Akinsanya K, Strack AM, Ehrhardt AG.

Curr Chem Genomics. 2012;6:38-47. doi: 10.2174/1875397301206010038. Epub 2012 Sep 20.

28.

An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genes.

Zhang L, McCabe T, Condra JH, Ni YG, Peterson LB, Wang W, Strack AM, Wang F, Pandit S, Hammond H, Wood D, Lewis D, Rosa R, Mendoza V, Cumiskey AM, Johns DG, Hansen BC, Shen X, Geoghagen N, Jensen K, Zhu L, Wietecha K, Wisniewski D, Huang L, Zhao JZ, Ernst R, Hampton R, Haytko P, Ansbro F, Chilewski S, Chin J, Mitnaul LJ, Pellacani A, Sparrow CP, An Z, Strohl W, Hubbard B, Plump AS, Blom D, Sitlani A.

Int J Biol Sci. 2012;8(3):310-27. doi: 10.7150/ijbs.3524. Epub 2012 Feb 9.

29.

Side chain SAR of bicyclic β-lactamase inhibitors (BLIs). 2. N-Alkylated and open chain analogs of MK-8712.

Chen H, Blizzard TA, Kim S, Wu J, Young K, Park YW, Ogawa AM, Raghoobar S, Painter RE, Wisniewski D, Hairston N, Fitzgerald P, Sharma N, Scapin G, Lu J, Hermes J, Hammond ML.

Bioorg Med Chem Lett. 2011 Jul 15;21(14):4267-70. doi: 10.1016/j.bmcl.2011.05.065. Epub 2011 May 27.

PMID:
21676616
30.

Thiophenyl oxime-derived phosphonates as nano-molar class C beta-lactamase inhibitors reducing MIC of imipenem against Pseudomonas aeruginosa and Acinetobacter baumannii.

Tan Q, Ogawa AM, Raghoobar SL, Wisniewski D, Colwell L, Park YW, Young K, Hermes JD, Dininno FP, Hammond ML.

Bioorg Med Chem Lett. 2011 Jul 15;21(14):4363-5. doi: 10.1016/j.bmcl.2011.04.122. Epub 2011 May 13.

PMID:
21664132
31.

[Intravascular embolization of the uterine arteries in the treatment of early postpartum haemorrhage--case report].

Lisowski A, Drelichowski S, Słoka-Sutkowska A, Wiśniewski D, Malinowski J.

Ginekol Pol. 2011 Feb;82(2):146-9. Polish.

PMID:
21574488
32.

A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo.

Ni YG, Di Marco S, Condra JH, Peterson LB, Wang W, Wang F, Pandit S, Hammond HA, Rosa R, Cummings RT, Wood DD, Liu X, Bottomley MJ, Shen X, Cubbon RM, Wang SP, Johns DG, Volpari C, Hamuro L, Chin J, Huang L, Zhao JZ, Vitelli S, Haytko P, Wisniewski D, Mitnaul LJ, Sparrow CP, Hubbard B, Carfí A, Sitlani A.

J Lipid Res. 2011 Jan;52(1):78-86. doi: 10.1194/jlr.M011445. Epub 2010 Oct 19.

33.

A proprotein convertase subtilisin-like/kexin type 9 (PCSK9) C-terminal domain antibody antigen-binding fragment inhibits PCSK9 internalization and restores low density lipoprotein uptake.

Ni YG, Condra JH, Orsatti L, Shen X, Di Marco S, Pandit S, Bottomley MJ, Ruggeri L, Cummings RT, Cubbon RM, Santoro JC, Ehrhardt A, Lewis D, Fisher TS, Ha S, Njimoluh L, Wood DD, Hammond HA, Wisniewski D, Volpari C, Noto A, Lo Surdo P, Hubbard B, Carfí A, Sitlani A.

J Biol Chem. 2010 Apr 23;285(17):12882-91. doi: 10.1074/jbc.M110.113035. Epub 2010 Feb 19.

34.

The nuclear membrane organization of leukotriene synthesis.

Mandal AK, Jones PB, Bair AM, Christmas P, Miller D, Yamin TT, Wisniewski D, Menke J, Evans JF, Hyman BT, Bacskai B, Chen M, Lee DM, Nikolic B, Soberman RJ.

Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20434-9. doi: 10.1073/pnas.0808211106. Epub 2008 Dec 15.

35.

Application of affinity selection/mass spectrometry to determine the structural isomer of parnafungins responsible for binding polyadenosine polymerase.

Adam GC, Parish CA, Wisniewski D, Meng J, Liu M, Calati K, Stein BD, Athanasopoulos J, Liberator P, Roemer T, Harris G, Chapman KT.

J Am Chem Soc. 2008 Dec 10;130(49):16704-10. doi: 10.1021/ja805531w.

PMID:
19049464
36.

PAP inhibitor with in vivo efficacy identified by Candida albicans genetic profiling of natural products.

Jiang B, Xu D, Allocco J, Parish C, Davison J, Veillette K, Sillaots S, Hu W, Rodriguez-Suarez R, Trosok S, Zhang L, Li Y, Rahkhoodaee F, Ransom T, Martel N, Wang H, Gauvin D, Wiltsie J, Wisniewski D, Salowe S, Kahn JN, Hsu MJ, Giacobbe R, Abruzzo G, Flattery A, Gill C, Youngman P, Wilson K, Bills G, Platas G, Pelaez F, Diez MT, Kauffman S, Becker J, Harris G, Liberator P, Roemer T.

Chem Biol. 2008 Apr;15(4):363-74. doi: 10.1016/j.chembiol.2008.02.016.

37.

Functional analysis of sites within PCSK9 responsible for hypercholesterolemia.

Pandit S, Wisniewski D, Santoro JC, Ha S, Ramakrishnan V, Cubbon RM, Cummings RT, Wright SD, Sparrow CP, Sitlani A, Fisher TS.

J Lipid Res. 2008 Jun;49(6):1333-43. doi: 10.1194/jlr.M800049-JLR200. Epub 2008 Mar 19.

38.

Expression, purification and crystallization of human 5-lipoxygenase-activating protein with leukotriene-biosynthesis inhibitors.

Xu S, McKeever BM, Wisniewski D, Miller DK, Spencer RH, Chu L, Ujjainwalla F, Yamin TT, Evans JF, Becker JW, Ferguson AD.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Dec 1;63(Pt 12):1054-7. Epub 2007 Nov 30.

39.

Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein.

Ferguson AD, McKeever BM, Xu S, Wisniewski D, Miller DK, Yamin TT, Spencer RH, Chu L, Ujjainwalla F, Cunningham BR, Evans JF, Becker JW.

Science. 2007 Jul 27;317(5837):510-2. Epub 2007 Jun 28.

40.

Effects of pH and low density lipoprotein (LDL) on PCSK9-dependent LDL receptor regulation.

Fisher TS, Lo Surdo P, Pandit S, Mattu M, Santoro JC, Wisniewski D, Cummings RT, Calzetta A, Cubbon RM, Fischer PA, Tarachandani A, De Francesco R, Wright SD, Sparrow CP, Carfi A, Sitlani A.

J Biol Chem. 2007 Jul 13;282(28):20502-12. Epub 2007 May 10.

41.

Quantification of change in phosphorylation of BCR-ABL kinase and its substrates in response to Imatinib treatment in human chronic myelogenous leukemia cells.

Liang X, Hajivandi M, Veach D, Wisniewski D, Clarkson B, Resh MD, Pope RM.

Proteomics. 2006 Aug;6(16):4554-64.

PMID:
16858728
42.

Time-resolved Forster resonance energy transfer assays for the binding of nucleotide and protein substrates to p38alpha protein kinase.

Zhang WX, Wang R, Wisniewski D, Marcy AI, LoGrasso P, Lisnock JM, Cummings RT, Thompson JE.

Anal Biochem. 2005 Aug 1;343(1):76-83.

PMID:
15979553
43.

Cell-based assays to detect inhibitors of fungal mRNA capping enzymes and characterization of sinefungin as a cap methyltransferase inhibitor.

Chrebet GL, Wisniewski D, Perkins AL, Deng Q, Kurtz MB, Marcy A, Parent SA.

J Biomol Screen. 2005 Jun;10(4):355-64.

PMID:
15964937
44.

Anthrax lethal factor inhibition.

Shoop WL, Xiong Y, Wiltsie J, Woods A, Guo J, Pivnichny JV, Felcetto T, Michael BF, Bansal A, Cummings RT, Cunningham BR, Friedlander AM, Douglas CM, Patel SB, Wisniewski D, Scapin G, Salowe SP, Zaller DM, Chapman KT, Scolnick EM, Schmatz DM, Bartizal K, MacCoss M, Hermes JD.

Proc Natl Acad Sci U S A. 2005 May 31;102(22):7958-63. Epub 2005 May 23.

45.

The membrane organization of leukotriene synthesis.

Mandal AK, Skoch J, Bacskai BJ, Hyman BT, Christmas P, Miller D, Yamin TT, Xu S, Wisniewski D, Evans JF, Soberman RJ.

Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6587-92. Epub 2004 Apr 14.

46.

Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies.

Clarkson B, Strife A, Wisniewski D, Lambek CL, Liu C.

Leukemia. 2003 Jul;17(7):1211-62. Review.

PMID:
12835715
47.

Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells.

Strife A, Wisniewski D, Liu C, Lambek CL, Darzynkiewicz Z, Silver RT, Clarkson B.

Mol Cancer Res. 2003 Jan;1(3):176-85.

48.

Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases.

Wisniewski D, Lambek CL, Liu C, Strife A, Veach DR, Nagar B, Young MA, Schindler T, Bornmann WG, Bertino JR, Kuriyan J, Clarkson B.

Cancer Res. 2002 Aug 1;62(15):4244-55.

49.

A peptide-based fluorescence resonance energy transfer assay for Bacillus anthracis lethal factor protease.

Cummings RT, Salowe SP, Cunningham BR, Wiltsie J, Park YW, Sonatore LM, Wisniewski D, Douglas CM, Hermes JD, Scolnick EM.

Proc Natl Acad Sci U S A. 2002 May 14;99(10):6603-6. Epub 2002 May 7.

50.

Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling.

Liang X, Wisniewski D, Strife A, Shivakrupa, Clarkson B, Resh MD.

J Biol Chem. 2002 Apr 19;277(16):13732-8. Epub 2002 Feb 1.

Supplemental Content

Loading ...
Support Center